Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Shares Outstanding (2020 - 2025)

RxSight's Shares Outstanding history spans 6 years, with the latest figure at $41.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 2.01% year-over-year to $41.2 million; the TTM value through Dec 2025 reached $41.2 million, up 2.01%, while the annual FY2025 figure was $41.2 million, 2.01% up from the prior year.
  • Shares Outstanding reached $41.2 million in Q4 2025 per RXST's latest filing, roughly flat from $41.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $41.2 million in Q4 2025 to a low of $4.1 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $31.8 million, with a median of $35.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: skyrocketed 2736674500.0% in 2021, then rose 1.45% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $27.4 million in 2021, then increased by 3.29% to $28.3 million in 2022, then rose by 27.84% to $36.1 million in 2023, then rose by 11.87% to $40.4 million in 2024, then increased by 2.01% to $41.2 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Shares Outstanding are $41.2 million (Q4 2025), $41.1 million (Q3 2025), and $40.9 million (Q2 2025).